The C-reactive protein-albumin-lymphocyte index: a novel biomarker for metabolic dysfunction-associated fatty liver disease across three ethnic cohorts.

In Model 1, when analyzing ln-CALLY categorized into quartiles, using Q1 as the reference group, a decreasing trend in the odds of MAFLD was observed across Q2, Q3, and Q4, with the Q4 group (highest ln CALLY) showing particularly lower odds (NHANES: OR = 0.21, 95% CI: 0.14–0.31; UK Biobank: OR = 0.17, 95% CI: 0.16–0.17, Taizhou Central Hospital: OR = 0.12, 95% CI: 0.06–0.21; all P < 0.001).

also in 47,180 other papers